- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00056667
Relaxation Response Training for the Treatment of Rheumatoid Arthritis
Relaxation Response, Somatic Style and Rheumatoid Arthritis
Study Overview
Status
Conditions
Detailed Description
RR training is a part of most multi-component psychosocial therapies for RA. RR training may decrease perceived psychosocial stress and autonomic tone, which in turn diminishes pain and the anticipatory anxiety associated with pain. RR training involves learning relaxation techniques which include diaphragmatic breathing, progressive skeletal muscle relaxation, and the induction of a state of focused attention on a chosen word, phrase, or image.
In clinical practice, RR training is generally administered as one component of RA therapy. In this study, the effectiveness of RR training will be evaluated when RR training is administered alone and in combination with a cognitive behavioral therapy program. The cognitive behavior techniques include problem solving, relabeling, enhanced awareness of pain behaviors, and attention refocusing. The effectiveness of RR training will be evaluated in comparison to standard RA education that includes topics such as the nature of RA disease, medical therapies, physical activities, nutrition, and pain mechanisms.
After a baseline assessment of health beliefs, RA severity, social support, and psychological distress, patients will be randomized to one of three study arms. Patients in Arm A will complete six individualized weekly RR training sessions. Patients will receive a 20-minute audiotape to guide them through the exercise; they are asked to practice 5 to 7 times per week. Patients in Arm B will learn cognitive behavioral and RR techniques during eight weekly sessions. Patients in Arm C will receive standard RA education. After the initial training, all patients will be followed up with monthly telephone conversations for 4 months. Patients will have follow-up study visits at Months 6 and 12. Follow-up study visits include a medical interview, physical exam, and blood tests.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham & Women'S Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- RA as defined by the American College of Rheumatology
- English literacy and fluency
Exclusion criteria
- Major medical condition or illness which limits life expectancy or results in severe symptoms or functional disability (Duke Severity of Illness score > 0.85)
- Fibromyalgia
- Received or currently receiving psychosocial treatment for RA
- Unavailability for Month 12 follow-up
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CBT plus relaxation response
Participants will receive cognitive behavioral therapy plus relaxation response training
|
The cognitive behavioral therapy program wwill incorporate relaxation training, a modified version of the RA treatment program developed by Bradley et al (1987) and shown to be effective.
The cognitive behavioral techniques include problem solving, relabeling, enhanced awareness of pain behaviors, and attention refocusing.
The RR component includes instruction in diaphragmatic breathing along with progressive skeletal muscle relaxation.
The intervention will be modified from the original program in that neither biofeedback training nor participation of family members will be included.
Consequently, the number of weekly group sessions will be reduced from 14 to 12. Homework will be given at the end of each session, to be completed and brought in for review to the next session.
Other Names:
|
Active Comparator: Relaxation Response
Participants will receive relaxation response training
|
The relaxation response (RR) consists of a set of integrated physiological changes elicited when a participant engages in the repetitive mental action of focusing on a word, phrase, or image, while passively ignoring distracting thoughts.
These changes include decreased oxygen consumption, heart rate, arterial blood pressure, respiratory rate, and arterial blood lactate, along with slight increases in skeletal muscle blood flow.
The long-term physiologic changes of participants eliciting the relaxation response are consistent with reduced norepinephrine end organ responsivity.
These latter changes provide a plausible psychophysiological mechanism for longer-term actions of the RR.
Other Names:
|
Placebo Comparator: Education
Participants will receive rheumatoid arthritis education
|
RA education programs have been widely used to supplement routine medical care.
They have been found to be of modest benefit, particularly in terms of knowledge about the condition and its treatment.
The long-term effects on pain and level of function are less.
When used as an attention control, such educational programs have been found to be as credible and as well attended as the active experimental treatment (Professor Francis Keefe, Personal Communication).
In this study, patients randomized to the control condition will receive 8 weekly sessions of RA education, in groups of 6-10 patients each, using portions of the Arthritis Self-Management Program and incorporating printed and videotaped materials available from the Arthritis Foundation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Somatic symptoms as assessed by the Rheumatoid Arthritis Symptom Questionnaire
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Role impairment and functional status as assessed with the Functional Status Questionnaire
Time Frame: 12 months
|
12 months
|
Medical care utilization as assessed with the hospital's automated encounter database
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Arthur J. Barsky, MD, Brigham & Women's Hospital, Boston, MA
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01AR047014 (U.S. NIH Grant/Contract)
- NIAMS-088
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
-
University Hospital, ToulouseCompletedRheumatoId ArthritisFrance
-
David Grant U.S. Air Force Medical CenterCompleted
-
TcLand Expression S.A.European CommissionTerminatedRheumatoId ArthritisFrance, Netherlands, Turkey, Czechia, Israel
Clinical Trials on Relaxation response and cognitive behavioral therapy
-
Massachusetts General HospitalCenters for Disease Control and PreventionCompleted
-
Brigham and Women's HospitalCompletedProstate CancerUnited States
-
Norwegian University of Science and TechnologyNorwegian Foundation for Health and RehabilitationCompletedObsessive-Compulsive DisorderNorway
-
University of Turin, ItalyRegione Piemonte; Fondazione CRT, Torino; Turin, ItalyUnknownMigraine | Cervical Pain | Tension Type HeadacheItaly
-
University of MichiganNational Institute of Mental Health (NIMH); Ohio State UniversityCompletedAnxiety Disorders | Generalized Anxiety Disorder | Anxiety | Social Anxiety Disorder | Panic Disorder | Social Phobia | Separation Anxiety Disorder | Specific Phobia | Phobia | Agoraphobia | Panic AttackUnited States
-
Stanford UniversityCompleted
-
Rhode Island HospitalNational Institute of Mental Health (NIMH)CompletedObsessive-Compulsive DisorderUnited States
-
Region of Southern DenmarkUniversite du Quebec en OutaouaisCompleted
-
Michelle G. NewmanCompletedGeneralized Anxiety DisorderUnited States
-
VA Office of Research and DevelopmentCompletedSchizophrenia | Schizoaffective DisorderUnited States